Featured Research

from universities, journals, and other organizations

Eye Blood Vessel Width May Indicate Coronary Heart Death Risk

Date:
July 13, 2006
Source:
BMJ Specialty Journals
Summary:
The caliber of the small veins and arteries in the eye may be a good indicator of a middle aged person's chances of dying from coronary heart disease, suggests research published ahead of print in Heart. The researchers analyzed the caliber of the vasculature of the retina in more than 3600 men and women over the age of 49.

The calibre of the small veins and arteries in the eye may be a good indicator of a middle aged person's chances of dying from coronary heart disease, suggests research published ahead of print in Heart.

The researchers analysed the calibre of the vasculature of the retina in more than 3600 men and women over the age of 49.

This was done by looking at detailed photographs of the back of the eye, measuring the diameters of the small arteries (arterioles) and small veins (venules), and calculating their ratio, known as the AVR.

Arterioles and venules are small branches of main arteries and veins, and their condition reflects the general state of the smaller blood vessels in the body, or microcirculation.

During the nine years of the study, 78 women (just over 4%) and 114 men (just under 8%) died from coronary heart disease.

Among those aged 49 and up to the age of 75, although relatively uncommon, deaths from coronary heart disease doubled if the venules were wider.

Wider venules have been linked to several risk factors for coronary heart disease, including smoking, systemic inflammation, high total cholesterol and obesity.

In women in this age narrower arterioles were also associated with a 50% increased risk of dying from coronary heart disease.

The authors point out that the numbers involved are small, as fewer people die from heart disease. But signs in the small vessels of the eye appear to be independent predictors of the risk of death from coronary heart disease among those under 75, particularly in women.

Retinal photography may be a useful non-invasive method of assessing this risk, they suggest.


Story Source:

The above story is based on materials provided by BMJ Specialty Journals. Note: Materials may be edited for content and length.


Cite This Page:

BMJ Specialty Journals. "Eye Blood Vessel Width May Indicate Coronary Heart Death Risk." ScienceDaily. ScienceDaily, 13 July 2006. <www.sciencedaily.com/releases/2006/07/060713091208.htm>.
BMJ Specialty Journals. (2006, July 13). Eye Blood Vessel Width May Indicate Coronary Heart Death Risk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/07/060713091208.htm
BMJ Specialty Journals. "Eye Blood Vessel Width May Indicate Coronary Heart Death Risk." ScienceDaily. www.sciencedaily.com/releases/2006/07/060713091208.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins